About Us
"Aging is Disease"
Upgrade and Expand the life span with our organ regeneration & healthcare platform

We, ROKIT Healthcare, endeavor and strive to change the world with our customized artificial organ platforms. We want to provide the safest and effective organ regeneration platform services with our expertise in regenerative medicine. I believe there is a paradigm shift in healthcare economics, and globally, there are needs in new therapeutic methods. Therefore, we would like to become a pioneer in this new paradigm of utilizing autologous cell, cell sheet technology, and 4D biofabrication technology.

You, Seokhwan


ROKIT, Inc. established
Biofabrication device ‘ROKIT INVIVO’ launched
ROKIT EU established collaboration with Fraunhofer IBMT
2018. 1.
Collaboration with domestic medical institutions
2018. 7.
Appointed as the lead underwriter for IPO
2018. 9.
Name change to ROKIT Healthcare, Inc
2018. 11.
Attended ISAP to announce Clinical research data from Skin Regeneration Platform
2019. 5.
Closing of $27 million in a Domestic Series B round
2019. 7.
ROKIT America, Inc. established
2019. 10.
ROKIT Healthcare Launching Show
2019. 11.
· Proceeded Cartilage Regeneration Pre-clinical Study at Massachusetts General Hospitals(MGH) · Won Tech Challenge award as a breakthrough technology company from AAPS (American Association of Pharmaceutical Scientists)
2019. 12.
Nominated as the top healthcare company from IFAH(International Forum on Advancements in Healthcare)
2020. 04.
Start DFURegen Clinical Trial in Korea
2020. 07.
DRADS Capital Investment where Dr. Rudolph E. Tanzi. Ph.d. a confounder

ROKIT HEALTHCARE is a global healthcare company committed to providing an effective autologous organ regeneration platform using its proprietary biofabrication technologies across all types of applicable diseases in the field of regenerative medicine.

Through a convergence of know-how’s and innovation in the areas of R&D (i.e. 4D bioprinting, autologous stem cell technologies, and human-derived biomaterials), surgical medicine, and regulatory affairs,  ROKIT Healthcare believes in supplying customized organ regeneration platform services that will drastically change the way we trust and manage the health of our own body.

Best Regenerative Solution

ROKIT Healthcare believes in accelerating the translation of the bioprinting technology from the bench to the clinic We are always seeking researchers and physicians around the world to help push the boundaries of the regeneration technology and share 4D bioprinting medical operation platforms for better health and quality of life worldwide. Join us in the creative and life-saving strife.

Open Innovation Center

ROKIT Healthcare works with a philosophy of “open innovation through convergence and experience”. We invite cross-disciplinary teams in academia, clinical centers, industries and regulatory affairs together to expedite translating the unique benefits of 4D printing into clinic for organ regeneration. We invite collaborative innovations in the fields of:

  • 4D biofabrication technologies and tools
  • Medical operations
  • Bioinks and accessories
  • Clean-bench bioreactors
  • Regulatory breakthroughs in 4D printing of medical devices